David M Markovitz Selected Research

Melanoma (Melanoma, Malignant)

7/2011	DEK expression in melanocytic lesions.
8/2009	Melanoma proliferation and chemoresistance controlled by the DEK oncogene.
9/2005	p300/CBP-associated factor drives DEK into interchromatin granule clusters.
12/2002	YY1 and NF-Y binding sites regulate the transcriptional activity of the dek and dek-can promoter.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David M Markovitz Research Topics

Disease

14	Infections 10/2022 - 05/2002
12	Neoplasms (Cancer) 03/2024 - 11/2002
4	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2018 - 01/2003
4	Inflammation (Inflammations) 01/2016 - 12/2006
4	Melanoma (Melanoma, Malignant) 07/2011 - 12/2002
3	Acquired Immunodeficiency Syndrome (AIDS) 06/2011 - 01/2002
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2008 - 12/2002
2	Human Influenza (Influenza) 01/2020 - 01/2019
2	Breast Neoplasms (Breast Cancer) 01/2012 - 10/2008
2	Carcinogenesis 02/2008 - 05/2003
2	Genetic Translocation (Chromosomal Translocation) 02/2008 - 12/2002
2	Hepatocellular Carcinoma (Hepatoma) 09/2005 - 12/2002
2	Glioblastoma (Glioblastoma Multiforme) 09/2005 - 12/2002
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024
1	Fibrosis (Cirrhosis) 11/2022
1	Chromosomal Instability (Chromosome Stability) 11/2022
1	Systemic Scleroderma (Systemic Sclerosis) 11/2022
1	Bites and Stings (Sting) 11/2022
1	Vasculitis (Vasculitides) 11/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	COVID-19 01/2021
1	Lupus Nephritis 05/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Disease Progression 01/2020
1	Teratocarcinoma 01/2019
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2019
1	Ovarian Epithelial Carcinoma 12/2018
1	Ovarian Neoplasms (Ovarian Cancer) 12/2018
1	Down Syndrome (Down's Syndrome) 12/2017
1	Arthritis (Polyarthritis) 01/2017
1	Starvation 12/2016
1	Virus Diseases (Viral Diseases) 12/2016
1	Bacterial Meningitis 01/2016
1	Meningitis 01/2016
1	Sepsis (Septicemia) 01/2016
1	HIV Infections (HIV Infection) 01/2014
1	Colitis 01/2013
1	Bacterial Infections (Bacterial Infection) 01/2013
1	Merkel Cell Carcinoma 08/2012
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 08/2012
1	Small Cell Carcinoma 08/2012
1	Genomic Instability 04/2011
1	Lymphoma (Lymphomas) 10/2008
1	Corneal Neovascularization 06/2007
1	Urinary Bladder Neoplasms (Bladder Cancer) 09/2005
1	Autoimmune Diseases (Autoimmune Disease) 09/2005
1	Necrosis 01/2003
1	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2002

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 11/2022 - 05/2003
7	VimentinIBA 05/2020 - 01/2003
6	RNA (Ribonucleic Acid)IBA 01/2020 - 02/2008
5	LectinsIBA 03/2024 - 01/2020
4	Polysaccharides (Glycans)IBA 03/2024 - 01/2019
4	AutoantigensIBA 01/2018 - 01/2003
4	DNA (Deoxyribonucleic Acid)IBA 12/2017 - 02/2008
3	Mannose (D-Mannose)IBA 03/2024 - 01/2019
3	Oncogene Proteins (Oncogene Protein)IBA 12/2018 - 12/2002
3	ChromatinIBA 01/2017 - 07/2011
2	Antiviral Agents (Antivirals)IBA 03/2024 - 01/2020
2	AntigensIBA 01/2023 - 01/2022
2	LipidsIBA 01/2022 - 12/2016
2	Glycoproteins (Glycoprotein)IBA 01/2022 - 01/2021
2	AntibodiesIBA 05/2020 - 02/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 01/2003
2	AutoantibodiesIBA 01/2018 - 02/2011
2	Chemotactic FactorsIBA 01/2017 - 12/2006
2	tat Gene Products (tat Protein)IBA 08/2014 - 09/2013
2	CytokinesIBA 01/2003 - 11/2002
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2022
1	Ad26COVS1IBA 11/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	SugarsIBA 01/2022
1	Immunoglobulin IsotypesIBA 05/2020
1	Histones (Histone)IBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	PlatinumIBA 01/2019
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2019
1	LigandsIBA 01/2018
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018
1	Nucleotide AptamersIBA 01/2017
1	Virulence Factors (Pathogenicity Factors)IBA 01/2016
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2013
1	Dextrans (Dextran)FDA Link 01/2013
1	Monoclonal AntibodiesIBA 08/2012
1	Tenofovir (Viread)FDA Link 06/2011
1	Anti-Infective Agents (Microbicides)IBA 06/2011
1	HeterochromatinIBA 04/2011
1	PhosphoproteinsIBA 02/2011
1	Nucleic AcidsIBA 10/2008
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 10/2008
1	Neutralizing AntibodiesIBA 02/2008
1	human DEK proteinIBA 02/2008
1	RNA Splice SitesIBA 02/2008
1	Angiogenesis InhibitorsIBA 06/2007
1	withaferin AIBA 06/2007
1	Nuclear Proteins (Protein, Nuclear)IBA 12/2006
1	ChemokinesIBA 03/2003

Therapy/Procedure

7	Therapeutics 03/2024 - 01/2017
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021
1	Immunotherapy 01/2021